Takeda makes major bispecific, ADC pact with Innovent for $1.2B upfrontnews2025-10-22T07:31:10+00:00October 22nd, 2025|Endpoints News|
10x Genomics files patent suits against Illuminanews2025-10-22T02:01:04+00:00October 22nd, 2025|Endpoints News|
Polaris Partners plans to raise $500M for latest biotech fundnews2025-10-22T01:57:20+00:00October 22nd, 2025|Endpoints News|
Genmab was one of three bidders before inking $8B Merus acquisitionnews2025-10-22T01:54:06+00:00October 22nd, 2025|Endpoints News|
Elevara raises $70M to test a breast cancer approach in rheumatoid arthritisnews2025-10-21T23:01:30+00:00October 21st, 2025|Endpoints News|
First impressions on the ground at HLTH 2025news2025-10-21T19:27:27+00:00October 21st, 2025|Endpoints News|
Grail raises $325M from Hims and others ahead of FDA bidnews2025-10-21T18:46:51+00:00October 21st, 2025|Endpoints News|
Cuban’s Cost Plus links with White House’s TrumpRx sitenews2025-10-21T18:34:02+00:00October 21st, 2025|Endpoints News|
Regeneron reaches patent deal with Celltrion over Eylea biosimilarnews2025-10-21T18:16:52+00:00October 21st, 2025|Endpoints News|
As China moves beyond ‘me-too,’ do Western regulators need to reconsider?news2025-10-21T16:38:56+00:00October 21st, 2025|Endpoints News|
